These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
484 related items for PubMed ID: 10684270
1. Inhibition of CD3/CD28-mediated activation of the MEK/ERK signaling pathway represses replication of X4 but not R5 human immunodeficiency virus type 1 in peripheral blood CD4(+) T lymphocytes. Popik W, Pitha PM. J Virol; 2000 Mar; 74(6):2558-66. PubMed ID: 10684270 [Abstract] [Full Text] [Related]
2. Envelope-dependent restriction of human immunodeficiency virus type 1 spreading in CD4(+) T lymphocytes: R5 but not X4 viruses replicate in the absence of T-cell receptor restimulation. Vicenzi E, Bordignon PP, Biswas P, Brambilla A, Bovolenta C, Cota M, Sinigaglia F, Poli G. J Virol; 1999 Sep; 73(9):7515-23. PubMed ID: 10438841 [Abstract] [Full Text] [Related]
5. R5 human immunodeficiency virus type 1 (HIV-1) replicates more efficiently in primary CD4+ T-cell cultures than X4 HIV-1. Schweighardt B, Roy AM, Meiklejohn DA, Grace EJ, Moretto WJ, Heymann JJ, Nixon DF. J Virol; 2004 Sep; 78(17):9164-73. PubMed ID: 15308712 [Abstract] [Full Text] [Related]
6. Differential effects of R5 and X4 human immunodeficiency virus type 1 infection on CD4+ cell proliferation and activation. Locher CP, Witt SA, Kassel R, Dowell NL, Fujimura S, Levy JA. J Gen Virol; 2005 Apr; 86(Pt 4):1171-1179. PubMed ID: 15784911 [Abstract] [Full Text] [Related]
7. A CCR5+ memory subset within HIV-1-infected primary resting CD4+ T cells is permissive for replication-competent, latently infected viruses in vitro. Terahara K, Iwabuchi R, Hosokawa M, Nishikawa Y, Takeyama H, Takahashi Y, Tsunetsugu-Yokota Y. BMC Res Notes; 2019 Apr 29; 12(1):242. PubMed ID: 31036079 [Abstract] [Full Text] [Related]
8. Evidence for a post-entry barrier to R5 HIV-1 infection of CD4 memory T cells. Vyakarnam A, Eyeson J, Teo I, Zuckerman M, Babaahmady K, Schuitemaker H, Shaunak S, Rostron T, Rowland-Jones S, Simmons G, Clapham P. AIDS; 2001 Sep 07; 15(13):1613-26. PubMed ID: 11546935 [Abstract] [Full Text] [Related]
9. Mechanisms involved in stimulation of human immunodeficiency virus type 1 replication by aminooxypentane RANTES. Marozsan AJ, Torre VS, Johnson M, Ball SC, Cross JV, Templeton DJ, Quiñones-Mateu ME, Offord RE, Arts EJ. J Virol; 2001 Sep 07; 75(18):8624-38. PubMed ID: 11507208 [Abstract] [Full Text] [Related]
10. Toll-Like Receptor 2 Ligation Enhances HIV-1 Replication in Activated CCR6+ CD4+ T Cells by Increasing Virus Entry and Establishing a More Permissive Environment to Infection. Bolduc JF, Ouellet M, Hany L, Tremblay MJ. J Virol; 2017 Feb 15; 91(4):. PubMed ID: 27928019 [Abstract] [Full Text] [Related]
14. Binding of human immunodeficiency virus type 1 to CD4 and CXCR4 receptors differentially regulates expression of inflammatory genes and activates the MEK/ERK signaling pathway. Popik W, Hesselgesser JE, Pitha PM. J Virol; 1998 Aug 15; 72(8):6406-13. PubMed ID: 9658081 [Abstract] [Full Text] [Related]
15. SDF-1-induced activation of ERK enhances HIV-1 expression. Montes M, Tagieva NE, Heveker N, Nahmias C, Baleux F, Trautmann A. Eur Cytokine Netw; 2000 Sep 15; 11(3):470-7. PubMed ID: 11022134 [Abstract] [Full Text] [Related]
16. Phosphatidylinositol 3-kinase regulates human immunodeficiency virus type 1 replication following viral entry in primary CD4+ T lymphocytes and macrophages. François F, Klotman ME. J Virol; 2003 Feb 15; 77(4):2539-49. PubMed ID: 12551992 [Abstract] [Full Text] [Related]
17. Early activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase, p38 mitogen-activated protein kinase, and c-Jun N-terminal kinase in response to binding of simian immunodeficiency virus to Jurkat T cells expressing CCR5 receptor. Popik W, Pitha PM. Virology; 1998 Dec 05; 252(1):210-7. PubMed ID: 9875330 [Abstract] [Full Text] [Related]
18. Selective regulation of human immunodeficiency virus-infected CD4(+) lymphocytes by a synthetic immunomodulator leads to potent virus suppression in vitro and in hu-PBL-SCID mice. Bahr GM, Darcissac EC, Castéran N, Amiel C, Cocude C, Truong MJ, Dewulf J, Capron A, Mouton Y. J Virol; 2001 Aug 05; 75(15):6941-52. PubMed ID: 11435574 [Abstract] [Full Text] [Related]
19. A novel role for tumor necrosis factor-alpha in regulating susceptibility of activated CD4+ T cells from human and nonhuman primates for distinct coreceptor using lentiviruses. Brice GT, Mayne AE, Villinger F, Ansari AA. J Acquir Immune Defic Syndr; 2000 May 01; 24(1):10-22. PubMed ID: 10877490 [Abstract] [Full Text] [Related]